Evidence map›Paper›PMID 19402960›Full record

ArticleEmerging infectious diseases2009

CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia.

Etienne Ruppé, Sopheak Hem, Sovannarith Lath, Valérie Gautier, Frédéric Ariey, Jean-Louis Sarthou, Didier Monchy, Guillaume Arlet

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comprehensive Genomic Analysis of UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  6. Characterization of beta-lactamase producingIranian journal of microbiology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Markers Specific toInternational journal of environmental research and public health · 2020
    Article
  12. Article
  13. Article
  14. Novel determination ofNew microbes and new infections · 2020
    Article
  15. Detection ofIranian journal of microbiology · 2019
    Article
  16. Article
  17. Study of class 1 integrons in multidrug-resistant uropathogenicIranian journal of basic medical sciences · 2018
    Article
  18. Article
  19. Molecular characterization ofNew microbes and new infections · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Etienne RuppéInstitut Pasteur du Cambodge, Phnom Penh, Cambodia. etienne.ruppe@gmail.com
Sopheak Hem
Sovannarith Lath
Valérie Gautier
Frédéric Ariey
Jean-Louis Sarthou
Didier Monchy
Guillaume Arlet
Institut Pasteur du Cambodge · KHSorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the recent global spread of CTX-M beta-lactamases in Escherichia coli isolates from community-acquired urinary tract infections (CA-UTIs), their dissemination has been little studied in developing countries. In a 2-year prospective study, we documented the prevalence of extended-spectrum beta-lactamases (ESBLs) in E. coli that were responsible for CA-UTIs in Phnom-Penh, Cambodia. Ninety-three E. coli strains were included. We observed a high prevalence of resistance to amoxicillin (88.2% of strains), cotrimoxazole (75.3%), ciprofloxacin (67.7%), gentamicin (42.5%), and third-generation cephalosporins (37.7%). A total of 34 strains carried ESBLs, all of which were CTX-M type. CTX-M carriage was associated with resistance to fluoroquinolones and aminoglycosides. U using repetitive extragenic palindromic-PCR, we identified 4 clusters containing 9, 8, 3, and 2 strains. The prevalence of CTX-M beta-lactamases has reached a critical level in Cambodia, which highlights the need for study of their spread in developing countries.

Indexed as

AdolescentAdultAgedAged, 80 and overAminoglycosidesAnti-Bacterial Agentsbeta-LactamasesCambodiaChildChild, PreschoolCommunity-Acquired InfectionsDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsFemaleFluoroquinolonesAminoglycosidesAnti-Bacterial Agentsbeta-LactamasesFluoroquinolones

Identifiers

PMID19402960
PMCPMC2687024
OpenAlexW2114714153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.